We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+21.72%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$272M
AUM Growth
+$46.5M
Cap. Flow
+$9.18M
Cap. Flow %
3.37%
Top 10 Hldgs %
26.6%
Holding
346
New
62
Increased
72
Reduced
60
Closed
95

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$5.92M
2
SPGI icon
S&P Global
SPGI
+$4.98M
3
AMZN icon
Amazon
AMZN
+$4.9M
4
CAH icon
Cardinal Health
CAH
+$4.73M
5
CHE icon
Chemed
CHE
+$4.63M

Top Sells

Rank Stock Value
1
CTAS icon
Cintas
CTAS
+$6.44M
2
MAA icon
Mid-America Apartment Communities
MAA
+$4.56M
3
HON icon
Honeywell
HON
+$4.16M
4
ROST icon
Ross Stores
ROST
+$4.03M
5
LSI
Life Storage, Inc.
LSI
+$3.83M

Sector Composition

Rank Sector Weight
1 Technology 23.4%
2 Healthcare 18.72%
3 Financials 12.56%
4 Consumer Staples 11.35%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LDOS icon
101
Leidos
LDOS
$17.3B
$306K 0.11%
3,050
+2,906
+2,018% +$286K
QCOM icon
102
Qualcomm
QCOM
$176B
$302K 0.11%
3,377
+905
+37% +$72.6K
FFIV icon
103
F5
FFIV
$22.7B
$296K 0.11%
+2,087
New +$281K
TROW icon
104
T. Rowe Price
TROW
$24.3B
$296K 0.11%
+2,373
New +$271K
MRSH
105
Marsh
MRSH
$91.5B
$295K 0.11%
2,748
+766
+39% +$77.5K
KHC icon
106
Kraft Heinz
KHC
$30B
$293K 0.11%
+8,944
New +$269K
KSU
107
DELISTED
Kansas City Southern
KSU
$285K 0.1%
+1,919
New +$270K
ALXN
108
DELISTED
Alexion Pharmaceuticals
ALXN
$285K 0.1%
+2,513
New +$267K
AOS icon
109
A.O. Smith
AOS
$8.7B
$284K 0.1%
+5,932
New +$259K
ALL icon
110
Allstate
ALL
$67.5B
$283K 0.1%
+2,851
New +$280K
AWK icon
111
American Water Works
AWK
$26.9B
$283K 0.1%
+2,180
New +$272K
VRSK icon
112
Verisk Analytics
VRSK
$25B
$283K 0.1%
+1,699
New +$268K
RMD icon
113
ResMed
RMD
$30.7B
$282K 0.1%
1,670
+1,648
+7,491% +$270K
EVRG icon
114
Evergy
EVRG
$19.2B
$281K 0.1%
+4,694
New +$278K
WST icon
115
West Pharmaceutical
WST
$24.9B
$280K 0.1%
1,329
– –
MA icon
116
Mastercard
MA
$493B
$278K 0.1%
913
+273
+43% +$77K
STX icon
117
Seagate
STX
$184B
$276K 0.1%
5,348
-28
-0.5% -$1.41K
CERN
118
DELISTED
Cerner Corp
CERN
$274K 0.1%
3,953
+3,901
+7,502% +$268K
CHRW icon
119
C.H. Robinson
CHRW
$17.5B
$271K 0.1%
+3,475
New +$262K
WTW icon
120
Willis Towers Watson
WTW
$32B
$269K 0.1%
1,403
+1,384
+7,284% +$265K
XLU icon
121
State Street Utilities Select Sector SPDR ETF
XLU
$22.7B
$269K 0.1%
9,078
+4,558
+101% +$131K
WEC icon
122
WEC Energy
WEC
$35.1B
$268K 0.1%
+2,947
New +$266K
XEL icon
123
Xcel Energy
XEL
$48.8B
$267K 0.1%
+4,190
New +$264K
FTNT icon
124
Fortinet
FTNT
$117B
$265K 0.1%
+9,675
New +$243K
IFF icon
125
International Flavors & Fragrances
IFF
$21.9B
$265K 0.1%
+2,056
New +$260K
3 4
5
6 7

Similar funds

SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
PEP
Providence Equity Partners Providence, Rhode Island $565M AUM 37.52% 1-Year Est. Return
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
BRIM
Broad Run Investment Management Arlington, Virginia $568M AUM 50.18% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Contravisory Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Contravisory Investment Management held 346 positions worth $272M, up 21% from $226M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Contravisory Investment Management deployed $9.18M of net new capital in Q2 2020, opening 62 new positions and adding to 72 existing holdings. Its largest new stake was Cardinal Health: 91,819 shares worth $5M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Walt Disney, an estimated $3.62M trimmed.

  • Contravisory Investment Management's largest Q2 2020 buy was Cardinal Health: 91,819 shares worth $5M.
  • Contravisory Investment Management added most to AbbVie in Q2 2020, an estimated $5.92M increase.
  • Contravisory Investment Management's biggest Q2 2020 reduction was Walt Disney, cutting an estimated $3.62M.
  • Contravisory Investment Management fully exited Cintas in Q2 2020, selling an estimated $6.44M.
  • Contravisory Investment Management's ten largest holdings make up 27% of its $272M portfolio in Q2 2020.
  • Contravisory Investment Management opened 62 new positions and closed 95 in Q2 2020.
  • Contravisory Investment Management's portfolio value rose 21% quarter-over-quarter to $272M.

Based on Contravisory Investment Management's 13F filing for Q2 2020, filed 9 Jul 2020.